Smartleaf Asset Management LLC Supernus Pharmaceuticals, Inc. Transaction History
Smartleaf Asset Management LLC
- $1.13 Trillion
- Q2 2025
A detailed history of Smartleaf Asset Management LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 869 shares of SUPN stock, worth $41,772. This represents 0.0% of its overall portfolio holdings.
Number of Shares
869
Previous 1,157
24.89%
Holding current value
$41,772
Previous $37.4 Million
27.52%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SUPN
# of Institutions
313Shares Held
61.7MCall Options Held
18.4KPut Options Held
0-
Black Rock Inc. New York, NY10.4MShares$500 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.21MShares$298 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.81MShares$231 Million2.66% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$145 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.76MShares$133 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.57B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...